These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1424123)

  • 21. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol.
    Fielding PE; Kawano M; Catapano AL; Zoppo A; Marcovina S; Fielding CJ
    Biochemistry; 1994 Jun; 33(22):6981-5. PubMed ID: 7515687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
    Nakabayashi T; Yamauchi K; Sugano M; Sano K; Tozuka M; Hidaka H
    Ann Clin Lab Sci; 2004; 34(3):287-98. PubMed ID: 15487703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
    Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
    Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
    Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ
    Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.
    Marcoux C; Lussier-Cacan S; Davignon J; Cohn JS
    Biochim Biophys Acta; 1997 Jun; 1346(3):261-74. PubMed ID: 9219911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroblotting of Immobiline DryPlates applied to identification of human plasma apolipoprotein A-I.
    Holmquist L
    Electrophoresis; 1988 Sep; 9(9):511-3. PubMed ID: 3149578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of prebeta-1 HDL in human plasma by an ultrafiltration-isotope dilution technique.
    O'Connor PM; Naya-Vigne JM; Duchateau PN; Ishida BY; Mazur M; Schoenhaus SA; Zysow BR; Malloy MJ; Kunitake ST; Kane JP
    Anal Biochem; 1997 Sep; 251(2):234-40. PubMed ID: 9299021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles.
    Brousseau T; Clavey V; Bard JM; Fruchart JC
    Clin Chem; 1993 Jun; 39(6):960-4. PubMed ID: 8504564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of small high density lipoprotein subclass by an improved immunoblotting technique.
    Atmeh RG; Robenek H
    J Lipid Res; 1996 Nov; 37(11):2461-9. PubMed ID: 8978497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The origin and metabolism of a nascent pre-β high density lipoprotein involved in cellular cholesterol efflux.
    Wróblewska M
    Acta Biochim Pol; 2011; 58(3):275-85. PubMed ID: 21750785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of physical exercise on plasma prebeta-1 high-density lipoprotein.
    Jafari M; Leaf DA; Macrae H; Kasem J; O'conner P; Pullinger C; Malloy M; Kane JP
    Metabolism; 2003 Apr; 52(4):437-42. PubMed ID: 12701055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of specific apolipoproteins determined by immunoblotting of baboon lipoproteins resolved by polyacrylamide gradient gel electrophoresis.
    Rainwater DL; Kammerer CM; Cheng ML; Sparks ML; VandeBerg JL
    Biochem Genet; 1992 Apr; 30(3-4):143-58. PubMed ID: 1590746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total parenteral nutrition and plasma lipoproteins in the rat: evidence for accelerated clearance of apo-A-I-rich HDL.
    Hajri T; Férézou J; Steinmetz P; Lutton C
    Biochim Biophys Acta; 1993 Feb; 1166(1):84-91. PubMed ID: 8431496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In addition to the high-density lipoprotein fraction, apolipoprotein C-III is detected in chylomicrons and the very low-density lipoprotein fraction from serum of normolipidemic cows.
    Katoh N
    J Vet Med Sci; 2001 Jan; 63(1):95-7. PubMed ID: 11217073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release.
    Briand O; Nizard FM; David-Dufilho M; Six I; Lestavel S; Brunet A; Fruchart JC; Torpier G; Bordet R; Clavey V; Duriez P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):69-77. PubMed ID: 15238221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.